Drop in convalescent plasma use at US hospitals linked to higher COVID-19 mortality rate

(Johns Hopkins University Bloomberg School of Public Health) A new study from researchers at Johns Hopkins Bloomberg School of Public Health and colleagues suggests a slowdown in the use of convalescent plasma to treat hospitalized COVID-19 patients led to a higher COVID-19 mortality during a critical period during this past winter's surge.